Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]
Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation
Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]
Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]
Bayer Announces Changes in Executive Leadership Team of Crop Science Division
Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]
Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer
Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]
Bayer to Invest Over €400 Million to Increase Access to Modern Contraception
Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]
Ada Health Secures £63m Investment to Enhance Assessment Tech
Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]
Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health
Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more